Monocyte-derived multipotent cell delivered programmed therapeutics to reverse idiopathic pulmonary fibrosis

Idiopathic pulmonary fibrosis (IPF) is a highly heterogeneous and fatal disease. However, IPF treatment has been limited by the low drug delivery efficiency to lungs and dysfunctional “injured” type II alveolar epithelial cell (AEC II). Here, we present surface-engineered nanoparticles (PER NPs) loa...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Xin, Xing, Lei, Wang, Yi, Yang, Chen-Xi, He, Yu-Jing, Zhou, Tian-Jiao, Gao, Xiang-Dong, Li, Ling, Hao, Hai-Ping, Jiang, Hu-Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7253157/
https://www.ncbi.nlm.nih.gov/pubmed/32518825
http://dx.doi.org/10.1126/sciadv.aba3167

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7253157/
https://www.ncbi.nlm.nih.gov/pubmed/32518825
http://dx.doi.org/10.1126/sciadv.aba3167

Ejemplares similares